1-193105562-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_016066.4(GLRX2):ā€‹c.77T>Cā€‹(p.Ile26Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000468 in 1,602,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00025 ( 0 hom., cov: 32)
Exomes š‘“: 0.000026 ( 0 hom. )

Consequence

GLRX2
NM_016066.4 missense

Scores

15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.836
Variant links:
Genes affected
GLRX2 (HGNC:16065): (glutaredoxin 2) The protein encoded by this gene is a member of the glutaredoxin family of proteins, which maintain cellular thiol homeostasis. These proteins are thiol-disulfide oxidoreductases that use a glutathione-binding site and one or two active cysteines in their active site. This gene undergoes alternative splicing to produce multiple isoforms, one of which is ubiquitously expressed and localizes to mitochondria, where it functions in mitochondrial redox homeostasis and is important for the protection against and recovery from oxidative stress. Other isoforms, which have more restrictive expression patterns, show cytosolic and nuclear localization, and are thought to function in cellular differentiation and transformation, possibly with a role in tumor progression. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.014562845).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GLRX2NM_016066.4 linkc.77T>C p.Ile26Thr missense_variant 1/4 NP_057150.2 Q9NS18-2
GLRX2NM_001243399.2 linkc.-2+56T>C intron_variant NP_001230328.1 Q9NS18

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GLRX2ENST00000367440.3 linkc.77T>C p.Ile26Thr missense_variant 1/41 ENSP00000356410.3 Q9NS18-2
GLRX2ENST00000472197.1 linkn.440+56T>C intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000251
AC:
38
AN:
151550
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000897
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000547
AC:
13
AN:
237578
Hom.:
0
AF XY:
0.0000233
AC XY:
3
AN XY:
128974
show subpopulations
Gnomad AFR exome
AF:
0.000781
Gnomad AMR exome
AF:
0.0000612
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000255
AC:
37
AN:
1450876
Hom.:
0
Cov.:
32
AF XY:
0.0000236
AC XY:
17
AN XY:
721270
show subpopulations
Gnomad4 AFR exome
AF:
0.000988
Gnomad4 AMR exome
AF:
0.0000458
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.03e-7
Gnomad4 OTH exome
AF:
0.0000334
GnomAD4 genome
AF:
0.000251
AC:
38
AN:
151550
Hom.:
0
Cov.:
32
AF XY:
0.000257
AC XY:
19
AN XY:
73998
show subpopulations
Gnomad4 AFR
AF:
0.000897
Gnomad4 AMR
AF:
0.0000656
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000101
Hom.:
0
Bravo
AF:
0.000264
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000824
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 12, 2021The c.77T>C (p.I26T) alteration is located in exon 1 (coding exon 1) of the GLRX2 gene. This alteration results from a T to C substitution at nucleotide position 77, causing the isoleucine (I) at amino acid position 26 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.2
DANN
Benign
0.55
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0015
N
LIST_S2
Benign
0.27
T
M_CAP
Benign
0.0032
T
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-1.1
T
PROVEAN
Benign
-0.020
N
REVEL
Benign
0.035
Sift
Benign
0.30
T
Sift4G
Benign
0.17
T
Polyphen
0.0010
B
Vest4
0.039
MVP
0.030
MPC
0.23
ClinPred
0.085
T
GERP RS
-0.79
gMVP
0.087

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1075660; hg19: chr1-193074692; API